...
首页> 外文期刊>Korean journal of radiology : >Ultrasonographic Indeterminate Lymph Nodes in Preoperative Thyroid Cancer Patients: Malignancy Risk and Ultrasonographic Findings Predictive of Malignancy
【24h】

Ultrasonographic Indeterminate Lymph Nodes in Preoperative Thyroid Cancer Patients: Malignancy Risk and Ultrasonographic Findings Predictive of Malignancy

机译:术前甲状腺癌患者的超声抑制淋巴结:恶性肿瘤的恶性风险和超声波调查结果

获取原文

摘要

OBJECTIVE:Proper management of lymph nodes (LNs) with ultrasonographic (US) indeterminate features in thyroid cancer patients remains elusive. We aimed to evaluate the malignancy risk and US findings predictive of malignancy for US indeterminate LNs in preoperative thyroid cancer patients through node-by-node correlation.MATERIALS AND METHODS:A total of 348 LNs in 284 thyroid cancer patients, who underwent fine-needle aspiration or core-needle biopsy between December 2006 and June 2015, were included. We determined the malignancy risks for US probably benign, indeterminate, and suspicious categories. For US indeterminate LNs, which had neither echogenic hilum nor hilar vascularity in the absence of any suspicious finding, US findings were compared between benign and metastatic LNs using Mann-Whitney U test and Fisher's exact test.RESULTS:US imaging diagnoses were probably benign in 20.7% (n = 72) cases, indeterminate in 23.6% (n = 82), and suspicious in 55.7% (n = 194). Malignancy risk of US indeterminate LNs (19.5% [16/82]) differed from those of the US probably benign (2.8% [2/72]) (p = 0.002) and US suspicious LNs (78.4% [152/194]) (p 0.001). Among US indeterminate LNs, there were no significant differences in short, long, and long-to-short diameter (L/S) ratios between benign and metastatic LNs (3.9 vs. 3.8 mm, p = 0.619; 7.3 vs. 7.3 mm, p = 0.590; 1.9 vs. 1.9, p = 0.652).CONCLUSION:US indeterminate LNs were frequently encountered during preoperative evaluation and had intermediate malignancy risk. Given the lack of discriminative power of size criteria and L/S ratio, clinical factors such as surgical strategy and node size should be considered for proper triage of US indeterminate LNs in thyroid cancer.Copyright ? 2020 The Korean Society of Radiology.
机译:目的:适当管理具有超声波(US)的淋巴结(LNS)甲状腺癌患者的不确定特征仍然难以捉摸。我们旨在评估恶性风险和美国对美国治疗的恶性风险和美国发现通过逐节点相关性,在术前甲状腺癌患者中不确定LNS。材料和方法:在284例甲状腺癌患者中共有348个LNS,患有细针的甲状腺癌患者包括在2006年12月和2015年6月之间的愿望或核心针活检。我们确定了美国的恶性风险可能是良性,不确定和可疑类别。对于我们不确定的LNS,在没有任何可疑发现的情况下既没有回声血清,也没有亨伦特血管性,使用Mann-Whitney U测试和Fisher的精确测试在良性和转移性LNS之间进行了比较了美国的调查结果。结果:美国成像诊断可能是良性的20.7%(n = 72)病例,在23.6%(n = 82)中不确定,并在55.7%(n = 194)中可疑。美国未确定LNS的恶性风险(19.5%[16/82])不同于美国可能良性(2.8%[2/72])(P = 0.002)和美国可疑LNS(78.4%[152/194]) (P <0.001)。在美国不确定的LNS中,良性和转移性LNS之间的短,长度和长达直径(L / S)比没有显着差异(3.9对3.8 mm,P = 0.619; 7.3和7.3 mm, P = 0.590; 1.9对1.9,P = 0.652)。结论:在术前评估期间,我们经常遇到不确定的LNS,并且具有中间恶性风险。鉴于缺乏规模标准和L / S比的歧视力,应考虑临床因素,例如手术策略和节点大小,以便在甲状腺癌中妥善介绍我们的适当三十次。 2020韩国放射学会。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号